Insulet also expects in 2028 to release the Omnipod Fully Closed Loop for Type 2, which will automate insulin delivery for patients with type 2 diabetes. It said the out-of-the-box product will be the ...
Biocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to ...
Zacks Investment Research on MSN
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
DexCom DXCM recently announced that it has received FDA clearance for its CGM-integrated basal insulin dosing optimizer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback